Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 22768138)

1.

Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats.

Delucchi F, Berni R, Frati C, Cavalli S, Graiani G, Sala R, Chaponnier C, Gabbiani G, Calani L, Del Rio D, Bocchi L, Lagrasta C, Quaini F, Stilli D.

PLoS One. 2012;7(6):e39836. doi: 10.1371/journal.pone.0039836. Epub 2012 Jun 29.

2.

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.

Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao L, Ren LQ, Liu NF.

Cardiovasc Diabetol. 2012 Sep 7;11:105. doi: 10.1186/1475-2840-11-105.

3.

Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats.

Liu Y, Qi H, Wang Y, Wu M, Cao Y, Huang W, Li L, Ji Z, Sun H.

Phytomedicine. 2012 Jun 15;19(8-9):693-8. doi: 10.1016/j.phymed.2012.04.007. Epub 2012 May 24.

PMID:
22633288
4.

Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.

Bresciani L, Calani L, Bocchi L, Delucchi F, Savi M, Ray S, Brighenti F, Stilli D, Del Rio D.

Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):408-15. doi: 10.1016/j.numecd.2013.09.008. Epub 2013 Oct 23.

PMID:
24462050
5.

Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.

Stilli D, Lagrasta C, Berni R, Bocchi L, Savi M, Delucchi F, Graiani G, Monica M, Maestri R, Baruffi S, Rossi S, Macchi E, Musso E, Quaini F.

Basic Res Cardiol. 2007 Nov;102(6):488-99. Epub 2007 Jun 26.

PMID:
17585379
6.

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.

Li CJ, Lv L, Li H, Yu DM.

Cardiovasc Diabetol. 2012 Jun 19;11:73. doi: 10.1186/1475-2840-11-73.

7.

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.

Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N.

Free Radic Biol Med. 2007 Sep 1;43(5):720-9. Epub 2007 May 10.

8.

Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.

Louhelainen M, Vahtola E, Forsten H, Merasto S, Kytö V, Finckenberg P, Leskinen H, Kaheinen P, Tikkanen I, Levijoki J, Mervaala E.

J Hypertens. 2009 Oct;27(10):2094-107. doi: 10.1097/HJH.0b013e32832f0ce4.

PMID:
19730126
9.

Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.

Kanamori H, Takemura G, Goto K, Tsujimoto A, Ogino A, Takeyama T, Kawaguchi T, Watanabe T, Morishita K, Kawasaki M, Mikami A, Fujiwara T, Fujiwara H, Seishima M, Minatoguchi S.

Am J Pathol. 2013 Mar;182(3):701-13. doi: 10.1016/j.ajpath.2012.11.009. Epub 2012 Dec 28.

10.

Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia.

Aydemir M, Ozturk N, Dogan S, Aslan M, Olgar Y, Ozdemir S.

Biol Trace Elem Res. 2012 Aug;148(2):216-23. doi: 10.1007/s12011-012-9350-8. Epub 2012 Feb 15.

PMID:
22351103
11.

Zinc-induced cardiomyocyte relaxation in a rat model of hyperglycemia is independent of myosin isoform.

Yi T, Cheema Y, Tremble SM, Bell SP, Chen Z, Subramanian M, LeWinter MM, VanBuren P, Palmer BM.

Cardiovasc Diabetol. 2012 Nov 2;11:135. doi: 10.1186/1475-2840-11-135.

12.

The cardiac neural stem cell phenotype is compromised in streptozotocin-induced diabetic cardiomyopathy.

El-Helou V, Proulx C, Béguin P, Assimakopoulos J, Gosselin H, Clement R, Villeneuve L, Huot-Marchand JE, Deblois D, Lajoie C, Calderone A.

J Cell Physiol. 2009 Aug;220(2):440-9. doi: 10.1002/jcp.21785.

PMID:
19388005
13.

Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.

Burstein B, Maguy A, Clément R, Gosselin H, Poulin F, Ethier N, Tardif JC, Hébert TE, Calderone A, Nattel S.

J Pharmacol Exp Ther. 2007 Dec;323(3):916-23. Epub 2007 Sep 17.

14.
15.

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.

Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, Lakkisto P, Mervaala E, Voipio-Pulkki LM, Laine M, Tikkanen I.

Diabetologia. 2004 Feb;47(2):325-30. Epub 2004 Jan 13.

PMID:
14722653
16.

Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.

Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.

Hypertens Res. 2007 May;30(5):427-37.

PMID:
17587755
17.

Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat.

Tuncay E, Zeydanli EN, Turan B.

J Bioenerg Biomembr. 2011 Dec;43(6):747-56. doi: 10.1007/s10863-011-9400-5. Epub 2011 Nov 30.

PMID:
22127436
18.

Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.

Cheng Y, Guo S, Liu G, Feng Y, Yan B, Yu J, Feng K, Li Z.

Int J Mol Med. 2012 Oct;30(4):870-6. doi: 10.3892/ijmm.2012.1083. Epub 2012 Jul 31.

PMID:
22859217
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk